Pfizer-BioNTech's COVID-19 Vaccine Giving 70% Protection Against Omicron, South Africa's Private Health Insurer Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
Go back to Pfizer-BioNTech's COVID-19 Vaccine Giving 70% Protection Against Omicron, South Africa's Private Health Insurer Says
December 14, 2021 4:08 PM EST
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for XELJANZ® / XELJANZ® XR (tofacitinib) for the treatment of adults with active ankylosing spondylitis (AS) who have had an inadequate... More
December 13, 2021 9:51 AM EST
UBS analyst Colin Bristow downgraded shares of Merck to Neutral (NYSE: MRK) on the lack of evident catalysts and the lack of visibility around key growth drivers.
The analyst also lowered the price target to $76.00 per share from the prior $98.00 as two key growth drivers - islatravir for HIV, molnupiravir for COVID - facilitated negative updates recentl
molnup's hospitalization/death relative risk reduction dropped from 48% (at interim) to ~30% (all evaluable patients) and... More
December 13, 2021 6:41 AM EST
Pfizer (NYSE: PFE) shares are up 2% in pre-open Monday after the company announced a deal to buy Arena Pharmaceuticals (Nasdaq: ARNA) in a $6.7 billion deal.
Pfizer will pay $100 per share in an all-cash transaction, which is a 100% premium compared to Fridays closing price of $49.94 per share.
Arena is a clinical-stage... More
